| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 8.896 | 25.895 | 29.042 | 34.019 | 33.277 | 37.677 |
| Total Income - EUR | - | - | - | - | 8.896 | 25.895 | 29.042 | 34.025 | 33.397 | 37.679 |
| Total Expenses - EUR | - | - | - | - | 8.866 | 20.901 | 23.197 | 27.337 | 28.057 | 29.031 |
| Gross Profit/Loss - EUR | - | - | - | - | 29 | 4.995 | 5.845 | 6.688 | 5.340 | 8.648 |
| Net Profit/Loss - EUR | - | - | - | - | -60 | 4.824 | 5.580 | 6.354 | 5.056 | 7.687 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Optidav Med Brasov S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 25 | 3.626 | 4.654 | 3.995 | 3.308 |
| Current Assets | - | - | - | - | 2.119 | 6.445 | 5.876 | 5.159 | 7.055 | 13.325 |
| Inventories | - | - | - | - | 1.551 | 1.581 | 1.510 | 1.451 | 2.252 | 2.041 |
| Receivables | - | - | - | - | 0 | 179 | 0 | 0 | 7 | 135 |
| Cash | - | - | - | - | 567 | 4.685 | 4.366 | 3.708 | 4.795 | 11.149 |
| Shareholders Funds | - | - | - | - | -17 | 4.807 | 5.628 | 6.403 | 9.518 | 13.333 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 2.162 | 1.664 | 3.873 | 3.410 | 1.532 | 3.300 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Optidav Med Brasov S.r.l.